Company MolMed S.p.A.
Equities
MLM
IT0001080248
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 30/07/20 | |
Kasper Møller
CTO | Chief Tech/Sci/R&D Officer | - | - |
Greg Shelton
HRO | Human Resources Officer | - | 30/06/21 |
Alberto Sobrero
PRN | Corporate Officer/Principal | - | - |
Robert Kerbel
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 31/12/19 | |
Corporate Officer/Principal | - | 31/10/21 | |
Luca Alberici
PRN | Corporate Officer/Principal | - | 31/12/05 |
Riccardo Perotta
AUD | Comptroller/Controller/Auditor | 75 | - |
Catia Traversari
PRN | Corporate Officer/Principal | - | 31/12/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 30/07/20 | |
Fabio Scoyni
CHM | Chairman | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 463,450,672 | 30,671,165 ( 6.618 %) | 0 | 6.618 % |
Company contact information
![address MolMed S.p.A.(MLM)](https://cdn.zonebourse.com/static/address/2178402.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
+10.74% | 25.92B | |
-13.50% | 26.03B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B | |
-12.61% | 10.64B |